These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 25003619

  • 1. Low bone mass in human immunodeficiency virus-infected climacteric women receiving antiretroviral therapy: prevalence and associated factors.
    Gomes DC, Valadares AL, de Moraes MJ, Lagrutta BB, Pinto-Neto AM, Costa-Paiva L.
    Menopause; 2015 Feb; 22(2):224-30. PubMed ID: 25003619
    [Abstract] [Full Text] [Related]

  • 2. Association between HIV infection and bone mineral density in climacteric women.
    Gomes DC, Valadares AL, Amaral E, Ferreira Nde O, Pinto-Neto AM, Baccaro LF, Costa-Paiva L.
    Arch Osteoporos; 2015 Feb; 10():33. PubMed ID: 26420601
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA, Nair V.
    Arch Osteoporos; 2012 Feb; 7():147-53. PubMed ID: 23225292
    [Abstract] [Full Text] [Related]

  • 4. Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.
    Pinto Neto LF, Ragi-Eis S, Vieira NF, Soprani M, Neves MB, Ribeiro-Rodrigues R, Miranda AE.
    J Clin Densitom; 2011 Feb; 14(4):434-9. PubMed ID: 22051092
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E, Ursini T, Agostinone A, Di Nicola AD, Polilli E, Sozio F, Vadini F, Pieri A, Trave F, De Francesco V, Capasso L, Borderi M, Manzoli L, Viale P, Parruti G.
    AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
    [Abstract] [Full Text] [Related]

  • 6. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
    Tsai MS, Hung CC, Liu WC, Chen KL, Chen MY, Hsieh SM, Sheng WH, Sun HY, Shih TT.
    J Microbiol Immunol Infect; 2014 Apr; 47(2):109-15. PubMed ID: 23073318
    [Abstract] [Full Text] [Related]

  • 7. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

  • 8. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
    Brown TT, Ruppe MD, Kassner R, Kumar P, Kehoe T, Dobs AS, Timpone J.
    J Clin Endocrinol Metab; 2004 Mar 30; 89(3):1200-6. PubMed ID: 15001610
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T, Saksawad R, Bunupuradah T, Wittawatmongkol O, Chuanjaroen T, Ubolyam S, Chaiwatanarat T, Nakavachara P, Maleesatharn A, Chokephaibulkit K.
    J Acquir Immune Defic Syndr; 2012 Dec 01; 61(4):477-83. PubMed ID: 22918157
    [Abstract] [Full Text] [Related]

  • 10. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP, Yu XB, Luo L, Han Y, Qiu ZF, Zuo LY, Li YL, Yu W, Li TS.
    Zhonghua Nei Ke Za Zhi; 2010 Aug 01; 49(8):649-52. PubMed ID: 20979781
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
    Paccou J, Viget N, Drumez E, Cortet B, Robineau O.
    Med Mal Infect; 2018 Oct 01; 48(7):442-448. PubMed ID: 29699830
    [Abstract] [Full Text] [Related]

  • 12. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
    Fernández-Rivera J, García R, Lozano F, Macías J, García-García JA, Mira JA, Corzo JE, Gómez-Mateos J, Rueda A, Sánchez-Burson J, Pineda JA.
    HIV Clin Trials; 2003 Oct 01; 4(5):337-46. PubMed ID: 14583850
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
    Guillemi S, Harris M, Bondy GP, Ng F, Zhang W, Lima VD, Michaels CE, Belzberg A, Montaner JS.
    J Clin Densitom; 2010 Oct 01; 13(4):456-61. PubMed ID: 20663695
    [Abstract] [Full Text] [Related]

  • 14. Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial.
    Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR.
    J Clin Endocrinol Metab; 2007 Apr 01; 92(4):1283-8. PubMed ID: 17227801
    [Abstract] [Full Text] [Related]

  • 15. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
    Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR.
    Clin Endocrinol (Oxf); 2007 Aug 01; 67(2):270-5. PubMed ID: 17547686
    [Abstract] [Full Text] [Related]

  • 16. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
    Schtscherbyna A, Pinheiro MF, Mendonça LM, Gouveia C, Luiz RR, Machado ES, Farias ML.
    Int J Infect Dis; 2012 Dec 01; 16(12):e872-8. PubMed ID: 23031418
    [Abstract] [Full Text] [Related]

  • 17. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ.
    J Natl Cancer Inst; 2004 Jul 21; 96(14):1070-6. PubMed ID: 15265968
    [Abstract] [Full Text] [Related]

  • 18. Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children.
    Mora S, Zamproni I, Beccio S, Bianchi R, Giacomet V, Viganò A.
    J Clin Endocrinol Metab; 2004 Jan 21; 89(1):24-8. PubMed ID: 14715822
    [Abstract] [Full Text] [Related]

  • 19. Bone disorders in human immunodeficiency virus infection.
    Glesby MJ.
    Clin Infect Dis; 2003 Jan 21; 37 Suppl 2():S91-5. PubMed ID: 12942380
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.
    Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P.
    Clin Infect Dis; 2003 Feb 15; 36(4):482-90. PubMed ID: 12567307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.